An Overview of Optimization of Spherical Crystallisation Process

DOI:

https://doi.org/10.37285/ijpsn.2013.6.4.2

Authors

  • N B Bhagat
  • A V Yadav
  • P R Mastud
  • R A Khutale

Abstract

In this article we describe the optimizing parameters in the process of spherical crystallisation. Particle engineering of active pharmaceutical agents is an innovative area of research in pharmaceutical industry because of several advantages. Spherical crystallization is one of the particle engineering technique in which drug directly gets crystallized and agglomerated into spherical shape. The spherical crystals can be obtained by different methods like solvent change, Quasi-emulsion droplet, ammonia diffusion and neutralisation. The optimization of process of spherical crystallization is important for obtaining the ideal spherical crystal agglomerates. It includes stirring rate, selection of solvent, pH, temperature etc. which affects on the physico-chemical properties of crystals. These optimizing parameters play its specific role in formation of spherical crystals. Stirring rate affects the shape as well as size of the final agglomerates and solvent selection helps in the formation of maximum amount of agglomerates in the system. The factors like pH and temperature should be maintained in case of drugs which show polymorphism. Apart from this, several others physical phenomenon or parameters like interfacial tension and rate of crystallisation are also important for thorough optimization of process.

 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Spherical crystals, Mode of agitation, Bridging liquid, Residence time

Downloads

Published

2013-12-31

How to Cite

1.
Bhagat NB, Yadav AV, Mastud PR, Khutale RA. An Overview of Optimization of Spherical Crystallisation Process. Scopus Indexed [Internet]. 2013 Dec. 31 [cited 2024 May 18];6(4):2203-9. Available from: https://www.ijpsnonline.com/index.php/ijpsn/article/view/673

Issue

Section

Review Articles

References

Agrawal GP, Bhadra S, Kumar M, Jain S, and Agrawal S (2004). Spherical crystallization of mefanamic acid. Pharm Tech. 66-76.

Akbuga J (1991). Furosemide-loaded ethyl cellulose microspheres prepared by spherical crystallisation technique: Morphology and release characteristics. Int. J Pharm. 76: 193-198.

Bhat H., Dixit V and Rodrigues B (2001). Experimental setup for rapid crystallisation using favoured chemical potential and hydrodynamic conditions. Bull. Mater. Sci. 24(5): 455–459.

Bhosale BB, Shivale DM (2011). Preparation and characterization of spherical crystals of valsartan for direct compression method. Int J Pharma Res Dev 22:333-339.

Biscans B, Amaro-Gonzalez D. (2002), Spherical agglomeration during crystallisation of an active pharmaceutical ingredient. Powder Tech. 128: 188-194.

Di martino P, Di Cristofaro R, Barthelemy C, Joris E, Fi;ippo GP, Sante M. (2000), Improved compression properties of propyphenazone spherical crystals. Int. J of Pharm. 197: 95-106.

Dixit M, Kulkarni PK, (2011), Preparation and characterization of spherical agglomerates of Piroxicam by neutralization method. Am J Drug Discovery and Development. 1-12.

Dixit M and Kulkarni PK. (2010), Spherical agglomeration of indomethacin by solvent change method. Int J Pharma. Res and Dev. 2(9): 33-38.

Dixit M, Kulkarni PK, and Kini AG (2010), Preparation and characterization of spherical agglomerates of ketoprofen by neutralisation method. Int J Pharma and Biosci. 1(4): P395-P406.

Dixit M, Kulkarni PK, Kini AG. (2010), Spherical agglomerates of ketoprofen by solvent change method. Int J of Pharma Sci Review and Res. 4(3): 129-135.

Gohle MC, Parikh RK, Shen H and Rubey RR (2003), Improvement in flowability and compressibility of Ampicilline Trihydrate by spherical crystallisation. Ind J Pharm Sci. 634-37.

Gupta MM, Kedawat M. (2011), Preparation and characterisation of spherical crystals of poorly flowable aceclofenac drug powder by using solvent change method after optimization of process parameters. 4(1): 121-123.

Hector GP, Jorge B, Carlo A, (1998), Preparation of Norfloxacin spherical agglomerates using the ammonia diffusion system. J. Pharm. Sci. 87(4): 519-523.

Hu R, Zhu J, Chen G, Sun Y, Mei K, and Li S (2006). Preparation of sustained release simavastatin by spherical crystallisation technique. Asian J of Pharm Sci. 47-52.

Jain SK, Chourasia MK, Jain A, Vaidya S. (2004), Utilisation of spherical crystallisation for preparation of directly compressible materials. Indian drugs. 41(6): 319-329.

Jain SK, Chourasia MK, Jain NK, Jai NK, and Jain S (2002). Preparation and characterization of agglomerates of flurbiprofen by spherical crystallisation technique. Indian J of Pharm sci. 287-291.

Jain NK, Chourasia MK, Vijaya R, Jain SK, and Jain S (2004). Preparation and characterisation of spherical crystal agglomerates for direct tableting by the spherical crystallisation technique. Indian drug. 41(4): 214-220.

Kawashima Y, Naito M, Lin SY, and Takenaka H (1983), An experimental study of the kinetics of the spherical crystallisation of sodium theophylline monohydrate. Powder Tech. 34: 255-260.

Kawashima Y, Okumura M and Takenaka H (1984). The effects of temperature on the spherical crystallisation of salicylic acid. Powder Tech. 39: 41-47.

Kawashima Y, Cui F, Takeuchi H, Niwa T, Hino T, Kiuchi K. (1995), Parameters determining the agglomeration behaviour and the micromeritics properties of spherically agglomerated crystals prepared by the spherical crystallisation technique with miscible solvent system. Int. J Pharm. 119: 139-147.

Khatry S., Garg J and Arora S (2012), Spherical crystallization: an overview. International Journal of Pharmacy Technology. 4(1): 1909-1928.

Kumar S, Chawla G and Bansal A (2008). Spherical Crystallization of Mebendazole to Improve Processability. Pharm. Dev. Technol. 13(6): 559-568.

Kumar D, Patel SK, Waghmode AP, Dhabale AS (2010), Spherical crystallization of gliclazide for improvement of micromeritics properties. Int J of Pharmacy and life science. 1(80): 463-466.

Kawashima Y, Aoki S, Takenaka H, Miyake .Y. (1984), Preparation of spherically agglomerated crystals of Aminophylline. J.Pharm Sci. 73(10): 1407-1410.

Kawashima Y, Imai M, Takeuchi H, Yamamoto H, Kamiya K. (2002), development of agglomerated crystals of ascorbic acid by the spherical crystallization technique for direct tableting, and evaluation of their compactibilities. Powder tech. 20: 251-262.

Lachman L., Liberman H., 1987. Kanig J., The theory and practice of industrial pharmacy. Varghese publication house. Third edition. Page No 293.

Mahanty S, Sruti J, Patra N, Bhanoji Rao ME (2010). Particle design of drugs by spherical crystallisation. Int. J Pharm Sci and Tech. 3(2): 912-918.

Maghsoodi M, Barghi L (2010), Design of agglomerated crystals of ibuprofen during crystallization: Influence of surfactant. Iranian J of Basic Med Sci. 14(1): 57-66.

Mishra VK, Dwivedi S, Sakalle P, Jain G, and Gupta D (2010), Method development for spherical crystallization of glibenclamide and evaluation of micromeritics properties. Drug Inv. Today. 2(2): 119-122.

Mitchell AG, Burt HM, (1980), Effect of habit modification on dissolution rate. Int J of Pharma 5: 239-251.

Morishima K, Kawashima Y, Takeuchi H, Niwa T, Hino T. (1993), Micromeritic characteristics and agglomeration mechanism in the spherical crystallisation of bucillamine by sperical agglomeration and the emulsion solvent diffusion methods. Powder Tech 76: 57-64.

Muller BW, Rasenack N, Hartenhauer H, (2003), Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. Int J Pharma. 254: 137-145.

Nokhodchi A, Maghsoodi M, Hassan-Zadeh D, Barzegar-Jalali M. (2007), Preparation of agglomerated crystals for improving flowability and compactibility of poorly flowable and compactible drugs and excipients. Powder Tech 175: 73-81.

Paradkar AR, Deshpande MC, Mahadik KR, Pawar AP. (1996). Evaluation of spherical crystallization as a particle size enlargement technique for aspirin. Indian J of Pharm Sci 32-34.

Parida R, Kumar S, Nabin K, Satish V. (2010), Overview of spherical crystallisation in pharmaceuticals. Int. J Pharm and Bioscience. 1(3): 1-6.

Parida R. (2010), Evaluation parameters for spherical crystallisation formed by spherical crystallisation technique. Int. J Pharm Biosci. 1(3): 1-10.

Patil SV, Sahoo SK. (2009), Spherical crystallisation: a method to improve tabletability. Research J. Pharma Tech. 2(2): 234-237.

Prathipati S, Ganesan V. (2011), Spherical crystallisation: A method to improve physicochemical properties. Int. J Pharm Sci Review and Res 6(1): 60-63.

Ram mohan Gupta V, Srikanth K, Sree Giri Prasad B, Naveen Kumar Reddy G, Sudheer B. (2011), Formulation and evaluation of directly compressible agglomerates of celecoxib. Int J of Pharma Sci and Nanotech. 3(4): 1191204.

Ramuson AC, Katta J. (2008), Spherical crystallisation of benzoic acid. Int J of Pharm. 348: 61-69.

Sano A, Kuriki T, Kawashima Y, Takeuchi H, Hino T, Niwa T. Particle design of Tolbutamide by the spherical crystallisation technique IV, Improved of dissolution and bioavailability of direct compression tablets prepared using Tolbutamide agglomerated crystals. Chem. Pharm. Bull. 40: 3030-3035.

Sarfaraz M, Arshad Ahmed KK, Doddayya H, Reddy SR, Udupi RH, (2011), Particle design of Aceclofenac-disintegrant agglomerates for direct compression by Crystallo-co-agglomeration technique. Asian J Pharm. 1(2): 40-48.

Szabo-Revesz P, Hasznos-Nezdei M, Farkas B, Goczo H, Pintye-Hodi K, Eros I. (2002), Crystal growth of drug materials by spherical crystallisation. J Cystal Growth. 2240-2245.

Takami K, Machimura H, Takado K, Inagaki M, Kawashima Y, (1996), Novel preparation of free flowing spherically agglomerated dibasic calcium phosphate anhydrous for direct tabletting. Chem Pharm Bull. 44(4): 686-870.

Tapas AR, Kawtikar PS, Sakarkar DM. (2009), Enhanced dissolution rate of felodipine using spherical agglomeration with Inutec SP1 by quasi emulsion solvent diffusion method. Res of Pharm Sci. 4(2): 77-84.

Teychene S, Sicre N, and Biscans B (2010). Is spherical crystallisation without additives possible? Chemical Engg. Res and design. 88: 1631-1638.

Ueda M, Nakamura Y, Makita H, Imasato Y, and Kawashima Y (1990). Particle design of enoxacin by spherical crystallization technique. Chem. Pharm. Bull. 38(9): 2537-2541.

Vyas SP, Jain A, and Kanaujia P (2007). Spherical crystallisation- a novel approach to develop microcapsules. International Workshop on Bioencapsulation, Vienna. 1-4.

Viswanathan CL, Kulkarni SK, and Kolwankar DR (2006), Spherical agglomeration of mefanamic acid and nabumetone to improve micromeritics and solubility: A technical note. AAPS PharmSciTech. 7(2): E1-E4.

Yadav VB and Yadav AV. (2009), Polymeric recrystallized agglomerates of cefuroxime axetil prepared by emulsion solvent diffusion technique. Tropical J Pharm Res. 8(4): 361-369.

Yadav VB and Yadav AV (2009), Comparative tabletting behaviour of carbamazepine granules with spherical agglomerated crystals prepared by spherical crystallisation technique. Int J ChemTech Res. 1(3): 476-482.

Yadav VB, Yadav AV. (2009), Effect of different and polymers on spherical agglomerates of griseofulvine by emulsion solvent diffusion system. Int J ChemTech Res. 1(2): 149-158.

Yadav VB, Yadav AV. (2009). Novel Particulate drug delivery systems by Emulsion solvent diffusion system: An overview. Journal of Pharmacy Research. 2(3): 468-479.

Yadav A.V, Yadav V.B. Designing of pharmaceuticals to improve physicochemical properties by spherical crystallisation technique. J Pharma Res. 1(2): 105-112.